Treatment Information

Back

Prostate Cancer treatment details. Chemotherapy.

Centro di Riferimento Oncologico, Aviano, Italy.

Survival: monthsCountry:Italy
Toxiciy Grade:4City/State/Province:Aviano
Treatments:ChemotherapyHospital:Centro di Riferimento Oncologico
Drugs:Journal:Link
Date:Jan 2004

Description:

Patients: This Phase II trial involved 28 patients with metastatic hormone-resistant prostate cancer. The median age was 66 years and the median PSA was 135.5 (range from 5.2 – 3940). Eleven patients had received prior radiation therapy.

Treatment: Treatment consisted of two chemotherapy drugs – mitoxantrone (novantrone) and vinorelbine (navelbine) with prednisone.

Toxicity: Grade 3-4 toxicities included leucopenia, anemia, and infection.

Results: Median overall survival was 11.9 months.

Correspondence: D. Bernardi, MD





Back